|Grant Affiliation:||Walker: bNabs after Infection and Immunization|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2015-04-02|
|Study Made Public:||2016-02-16|
Tier 1 and Tier 2 neutralization evaluation of plasma samples from 47 HIV+ individuals from an clinical HIV-1 observation cohort in Germany
CAVD 485 is an immunogenicity study of broadly neutralizing antibodies.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.